We are live on ! Find out more
BLTE

Belite Bio
BLTE

75 hedge funds and large institutions have $1.42B invested in Belite Bio in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

23% more capital invested

Capital invested by funds: $1.15B → $1.42B (+$269M)

9% more funds holding

Funds holding: 69 → 75 (+6)

4% more ownership

Funds ownership: 19.17% → 23.17% (+4%)

Holders
75
Holders Change
+6
Holders Change %
+8.7%
% of All Funds
0.92%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.06%
New
28
Increased
26
Reduced
15
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
+$187M
2
UBS Group
UBS Group
Switzerland
+$108M
3
Holocene Advisors
Holocene Advisors
New York
+$69M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$47.4M
5
Morgan Stanley
Morgan Stanley
New York
+$29.2M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$69.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$45.5M
3
PA
Perceptive Advisors
New York
-$44.1M
4
Marshall Wace
Marshall Wace
United Kingdom
-$30.8M
5
WSL
Western Standard LLC
California
-$9.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Aquatic Capital Management
Illinois
$3.24M +$3.41M +20,294 New
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.13M +$3.3M +19,600 New
Squarepoint
28
Squarepoint
New York
$2.71M +$2.86M +16,981 New
State Street
29
State Street
Massachusetts
$2.56M +$51.8K +308 +2%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$2.55M +$74.5K +443 +3%
TI
31
Trexquant Investment
Connecticut
$2.4M +$2.53M +15,072 New
XT
32
XTX Topco
Cayman Islands
$2.4M +$2.53M +15,058 New
BCP
33
Balance Capital Partners
New York
$2.31M +$2.44M +14,500 New
VA
34
Verdad Advisers
Massachusetts
$2.2M +$2.32M +13,813 New
Jane Street
35
Jane Street
New York
$1.95M -$3.38M -20,096 -62%
HF
36
HRT Financial
New York
$1.74M +$464K +2,758 +34%
Blackstone Inc
37
Blackstone Inc
New York
$1.7M +$1.8M +10,692 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$1.66M -$3.03K -18 -0.2%
HS
39
HighVista Strategies
Massachusetts
$1.28M +$1.35M +8,033 New
VCM
40
Voleon Capital Management
California
$1.26M +$1.33M +7,883 New
Barclays
41
Barclays
United Kingdom
$1.09M +$445K +2,646 +63%
AIP
42
Arrowpoint Investment Partners
Singapore
$957K +$497K +2,955 +97%
Amundi
43
Amundi
France
$671K +$708K +4,210 New
SP
44
SmartHarvest Portfolios
Washington
$668K +$505 +3 +0.1%
Bank of America
45
Bank of America
North Carolina
$602K +$324K +1,926 +104%
HNWAG
46
High Net Worth Advisory Group
Florida
$558K – – –
CF
47
Convergence Financial
Missouri
$473K +$499K +2,968 New
Ameriprise
48
Ameriprise
Minnesota
$441K -$1.76M -10,454 -79%
EGM
49
Engineers Gate Manager
New York
$397K +$419K +2,489 New
AC
50
AXQ Capital
New Jersey
$378K +$399K +2,372 New
1
2
3 4

BLTE Hedge Fund Activity: Q1 2026 in Review

75 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q1 2026, worth a combined $1.42B — up 23% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BLTE positions and 21 closed out — a net gain of 7 holders — while 26 added to existing stakes and 15 trimmed.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $187M. The largest seller was RA Capital Management, exiting entirely with an estimated $69.2M sold.

  • 75 institutional investors held Belite Bio (BLTE) as of Q1 2026, up from 69 in Q4 2025.
  • Funds reported $1.42B of Belite Bio stock for Q1 2026, up 23% quarter-over-quarter.
  • 28 funds opened new Belite Bio positions in Q1 2026 and 21 closed out, a net change of +7 holders.
  • The largest Belite Bio buyer in Q1 2026 was Paradigm Biocapital Advisors, an estimated $187M added.
  • The largest Belite Bio seller in Q1 2026 was RA Capital Management, an estimated $69.2M sold.

Based on aggregated 13F filings for Q1 2026.